A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
This report aims to provide a comprehensive presentation of the global market for Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines. This report contains market size and forecasts of Vaccines in global, including the following market information:
- Global Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Vaccines companies in 2022 (%)
The global Vaccines market was valued at US$ 46590 million in 2022 and is projected to reach US$ 67140 million by 2029, at a CAGR of 5.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
We surveyed the Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vaccines Market Segment Percentages, by Type, 2022 (%)
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
Global Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vaccines Market Segment Percentages, by Application, 2022 (%)
- Rabies vaccine
- Influenza vaccine
- HPV vaccine
- Hepatitis B
- Hepatitis A
- Leprosy vaccine
- Polio vaccine
- JE vaccine
- Others
Global Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Vaccines revenues share in global market, 2022 (%)
- Key companies Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Vaccines sales share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- GSK
- Sanofi
- Merck
- Pfizer
- Novartis(GSK)
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
- Jintan
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Vaccines, market overview.
- Chapter 2: Global Vaccines market size in revenue and volume.
- Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Vaccines capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
